Improved Prognosis in HER2-Low Breast Cancer Patients with Reduced Ki67 Index After Neoadjuvant Chemotherapy: A Multi-Center Retrospective Study [0.03%]
HER2低表达型乳腺癌患者新辅助化疗后Ki67指数下降者预后更佳：多中心回顾性研究
Man Huang,Yudi Jin,Mengyuan Wang et al.
Man Huang et al.
Background: HER2-low breast cancer represents a distinct subgroup with unique clinical characteristics and treatment challenges. Nevertheless, it remains uncertain whether there exists a distinction in δKi67 between pati...
Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers [0.03%]
luminal型乳腺癌中的人白细胞抗原Ⅰ类表达和自然杀伤细胞浸润及其与预后特征的相关性
Maria Vernet-Tomas,Ivonne Vazquez,Francesc Olivares et al.
Maria Vernet-Tomas et al.
Purpose: The aim of this study was to determine whether low HLA-I expression and NK cells infiltration are related to prognostic features in breast cancer, as observed in cancers in other locations and non-hormone depende...
Investigating the Correlation Between Long-Term Response in Patients with Metastatic HER2+ Breast Cancer and the Activity of Regulatory T Cells: A Retrospective Study [0.03%]
转移性HER2阳性乳腺癌患者长期反应与调节性T细胞活性相关性的回顾性研究
Mustafa Degirmenci,Gulden Diniz,Dudu Solakoglu Kahraman et al.
Mustafa Degirmenci et al.
Background: Trastuzumab is commonly utilized in the management of metastatic HER2-positive breast cancer. Our main goal was to examine the clinical outcomes and immune markers of patients who received trastuzumab and chem...
Ultra-Hypofractionated Whole Breast Radiotherapy with Automated Hybrid-VMAT Technique: A Pilot Study on Safety, Skin Toxicity and Aesthetic Outcomes [0.03%]
自动混合VMAT技术的超低分次量全乳放射治疗：一项关于安全性、皮肤毒副作用和美容效果的研究
Mariangela Boccardi,Savino Cilla,Mara Fanelli et al.
Mariangela Boccardi et al.
Purpose: The most prevalent treatment-related side effect related to adjuvant radiotherapy (RT) for breast cancer is acute skin toxicity in the irradiated area. The purpose of this single-institution pilot study is to pro...
Plasma Exosome miR-203a-3p is a Potential Liquid Biopsy Marker for Assessing Tumor Progression in Breast Cancer Patients [0.03%]
乳腺癌患者血浆外泌体miR-203a-3p有望成为评估肿瘤进展的液体活检标志物
Xin Yang,Lei Fan,Jicheng Huang et al.
Xin Yang et al.
Background: Timely detection of tumor progression in breast cancer (BC) patients is critical for therapeutic management and prognosis. Plasma exosomal miRNAs are potential liquid biopsy markers for monitoring tumor progre...
Comparative Analysis and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in Breast Cancer Treatment [0.03%]
乳腺癌治疗中人表皮生长因子受体2（HER2）和滋养层细胞表面抗原2（Trop-2）靶向抗体药物偶联物的比较分析及未来前景
Xiaojuan Gao,Tiansheng Bu,Wenying Wang et al.
Xiaojuan Gao et al.
Breast cancer remains the most prevalent malignancy among women globally, presenting significant challenges in therapeutic strategies due to tumor heterogeneity, drug resistance, and adverse side effects. Recent advances in targeted therapi...
Elevated Risk of Adverse Prognosis in Patients with T2-3 Stage Breast Cancer Exhibiting Non-Pathological Complete Response Following Neoadjuvant Chemotherapy: Significance of Regenerating Islet-Derived Family Member 4 [0.03%]
新辅助化疗后未达到病理完全缓解的T2-3期乳腺癌患者的不良预后风险升高：再生胰岛衍生4蛋白的意义
Fan Li,Chuan-Guo Chen,Jiao-Fei Wei et al.
Fan Li et al.
Objective: In this study, we aimed to establish the role of regenerating islet-derived family member 4 (Reg IV) as an independent risk factor and prognostic predictor in patients with T2-3 stage breast cancer who exhibit ...
Unraveling the Role of PCDH9 in Breast Cancer and Identifying Therapeutic Strategies for PCDH9-Deficient Tumors [0.03%]
揭示PCDH9在乳腺癌中的作用及鉴定PCDH9缺陷型肿瘤的治疗策略
Ruixi Li,Lulu Liu,Yong Liu et al.
Ruixi Li et al.
Introduction: Protocadherin 9 (PCDH9), a member of the cadherin superfamily of transmembrane proteins, plays a role in cell adhesion and neural development. Recent studies suggest that PCDH9 may function as a tumor suppre...
Comparative Analysis of Dosimetry: IMRT versus 3DCRT in Left-Sided Breast Cancer Patients with Considering Some Organs in Out - of - Field Borders [0.03%]
左乳腺癌患者IMRT与三维适形放疗(OFS内和OFS外器官剂量学比较研究)
Shaimaa G Ghazy,Mostafa A Abdel-Maksoud,Ibrahim A Saleh et al.
Shaimaa G Ghazy et al.
Purpose: The local management approach for node-positive breast cancer has undergone substantial evolution. Consequently, there exists a pressing need to enhance our treatment strategies by placing greater emphasis on pla...
Antimicrobial and Cytotoxic Effect of Bornetella Nitida Green Algae Isolate on MCF-7 Breast Cancer [0.03%]
Bornetella Nitida 绿藻对MCF-7乳腺癌的抗菌和细胞毒性作用
Yuni Elsa Hadisaputri,Nunuk Hariani Soekamto,Pratiwi Pudjiastuti et al.
Yuni Elsa Hadisaputri et al.
Introduction: Marine algae are increasingly becoming a potential resource for new drugs. In recent decades, including Bornetella nitida (B. nitida). Meanwhile, antimicrobial and anticancer agents are the first line of cho...